TrialJAMA network open2022

Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial.

David T Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.